PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore whether the GLP-1 receptor agonist exenatide, may
prevent glucocorticoid-induced glucometabolic abnormalities and beta-cell dysfunction in
healthy subjects.
Phase:
N/A
Details
Lead Sponsor:
VU University Medical Center
Collaborator:
National Research Council, Institute of Biomedical Engineering